News | May 13, 2022
Increased prevalence of diabetes and product innovation to boost insulin pens market in India, says GlobalData
India has the second-largest number of adults with diabetes globally, after China
India has the second-largest number of adults with diabetes globally, after China
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
RNA extraction free kit to deliver results in just 45 minutes
The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali
Subscribe To Our Newsletter & Stay Updated
